pargyline has been researched along with Complications of Diabetes Mellitus in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pickering, BI | 1 |
1 other study available for pargyline and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Parglyline hydrochloride and methyclothiazide combined in the treatment of hypertension in diabetic patients.
Topics: Adult; Aged; Diabetes Complications; Female; Humans; Hypertension; Male; Methyclothiazide; Middle Ag | 1968 |